Genetic Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . Genetic Technologies
GTG Stock   0.04  0.00  0.00%   
Genetic Technologies financial statements provide useful quarterly and yearly information to potential Genetic Technologies investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genetic Technologies financial statements helps investors assess Genetic Technologies' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genetic Technologies' valuation are summarized below:
Gross Profit
6 M
Profit Margin
(1.24)
Market Capitalization
5.7 M
Enterprise Value Revenue
0.7091
Revenue
9.7 M
There are currently eighty-eight fundamental trends for Genetic Technologies that can be evaluated and compared over time across competitors. All traders should confirm Genetic Technologies' regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Genetic Technologies Total Revenue

5.35 Million

Check Genetic Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genetic Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 508.1 K, Interest Expense of 83.6 K or Total Revenue of 5.3 M, as well as many indicators such as . Genetic financial statements analysis is a perfect complement when working with Genetic Technologies Valuation or Volatility modules.
  
This module can also supplement various Genetic Technologies Technical models . Check out the analysis of Genetic Technologies Correlation against competitors.
For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.

Genetic Technologies Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.9 M6.2 M12.1 M
Very volatile
Other Current Liabilities940.6 K1.1 M1.1 M
Very volatile
Total Current Liabilities4.4 M4.2 M2.3 M
Slightly volatile
Total Stockholder Equity1.7 M1.8 M9.6 M
Very volatile
Property Plant And Equipment Net251.3 K264.5 K441.9 K
Very volatile
Accounts Payable851.7 K1.5 M677.9 K
Slightly volatile
Cash969.6 K1 M8 M
Very volatile
Non Current Assets Total2.4 M2.5 M2.4 M
Pretty Stable
Cash And Short Term Investments969.6 K1 M8 M
Very volatile
Net Receivables2.2 M2.1 M736 K
Slightly volatile
Common Stock Total Equity84.9 M161.1 M112.3 M
Slightly volatile
Common Stock Shares Outstanding263.1 M132.2 M309.7 M
Slightly volatile
Liabilities And Stockholders Equity5.9 M6.2 M12.3 M
Very volatile
Inventory196.1 K206.5 K451.6 K
Slightly volatile
Total Liabilities2.3 M4.4 M2.4 M
Slightly volatile
Property Plant And Equipment Gross946.1 K1.5 M761.8 K
Slightly volatile
Total Current Assets3.5 M3.7 M9.6 M
Very volatile
Common Stock99.3 M163.8 M116.8 M
Slightly volatile
Property Plant Equipment876.6 K539.3 K574.9 K
Very volatile
Short and Long Term Debt Total509.7 K875.2 K690.1 K
Pretty Stable
Good Will2 M1.8 M4.6 M
Slightly volatile
Other Current Assets390.1 K341.7 K488.1 K
Slightly volatile
Short Term Debt894.9 K852.3 K234.2 K
Slightly volatile
Short Term Investments17.9 K18.8 K29.3 K
Slightly volatile
Non Current Liabilities Total152.6 K160.6 K494.1 K
Pretty Stable
Accumulated Other Comprehensive Income4.3 M4.4 M5.9 M
Slightly volatile
Other Liabilities133.1 K175.2 K140.7 K
Pretty Stable
Net Tangible Assets11.1 M8.7 M8.1 M
Slightly volatile
Short and Long Term Debt845.6 K579.2 K1.1 M
Slightly volatile
Net Invested Capital2.4 M2.5 M9.8 M
Pretty Stable
Capital Stock164.9 M163.8 M137.9 M
Slightly volatile
Capital Lease Obligations328.1 K231.6 K416.3 K
Pretty Stable

Genetic Technologies Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization508.1 K534.9 K392.3 K
Slightly volatile
Total Revenue5.3 M7.7 M3.8 M
Very volatile
Other Operating Expenses9.7 M7.7 M9.9 M
Pretty Stable
Cost Of Revenue3.9 M3.8 M1.6 M
Slightly volatile
Total Operating Expenses3.7 M3.9 M8.2 M
Slightly volatile
Selling General Administrative10.7 M10.2 M4.5 M
Slightly volatile
Selling And Marketing Expenses2.3 M2.6 M2.7 M
Slightly volatile
Research Development715.1 K752.8 K2.2 M
Slightly volatile
Minority Interest9.4 K9.9 K25.8 K
Slightly volatile
Non Recurring334.2 K376 K409.5 K
Slightly volatile
Interest Income72.6 K119.5 K66.8 K
Pretty Stable
Reconciled Depreciation488.7 K534.9 K405.8 K
Slightly volatile

Genetic Technologies Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation508.1 K534.9 K405.7 K
Slightly volatile
Capital Expenditures31.3 K33 K121.5 K
Very volatile
End Period Cash Flow969.6 K1 M8 M
Very volatile
Issuance Of Capital Stock2.4 M2.6 M6 M
Pretty Stable

Genetic Fundamental Market Drivers

Cash And Short Term Investments1 M

About Genetic Technologies Financial Statements

Genetic Technologies shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Genetic Technologies investors may analyze each financial statement separately, they are all interrelated. The changes in Genetic Technologies' assets and liabilities, for example, are also reflected in the revenues and expenses on on Genetic Technologies' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue741.6 K778.7 K
Total Revenue7.7 M5.3 M
Cost Of Revenue3.8 M3.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genetic Stock Analysis

When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY